Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2012
08/29/2012EP2491949A1 Peptides derived from the major allergen of ragweed (ambrosia artemisiifolia) and uses thereof
08/29/2012EP2491948A1 Peptides derived from the major allergen of ragweed (ambrosia artemisiifolia) and uses thereof
08/29/2012EP2491947A2 Vaccine
08/29/2012EP2491946A1 Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof
08/29/2012EP2491945A1 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
08/29/2012EP2491940A2 Method for inducing cytotoxic T-cells, cytotoxic T-cell inducer, and pharmaceutical composition and vaccine employing same
08/29/2012EP2491142A1 Producing an immune response for reducing the risk of developing brucellosis
08/29/2012EP2491058A1 Modulators of hepatocyte growth factor activator
08/29/2012EP2491057A2 Human recombinant monoclonal antibody that specifically binds to vcam-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells
08/29/2012EP2490724A2 Compositions for improving migration potential of stem cells
08/29/2012EP2490720A1 Anti-gcc antibody molecules and related compositions and methods
08/29/2012EP2490719A2 Methods of using anti-cd3 antibodies to prevent weight gain
08/29/2012EP2490718A1 Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
08/29/2012EP2490717A1 Influenza vaccine
08/29/2012EP2490716A1 Detection of a circovirus in calves suffering from bovine neonatal pancytopenia
08/29/2012EP2490715A1 Novel dosing regimen and method of treatment
08/29/2012EP2490714A2 Anti-cd3 antibody dosing in autoimmune disease
08/29/2012EP2490713A2 Cancer immunotherapy and method of treatment
08/29/2012EP2490698A1 Modulation of axon degeneration
08/29/2012CN1997751B Antibodies and related molecules that bind to PSCA proteins
08/29/2012CN1997395B Drug having regulatory cell ligand contained in liposome
08/29/2012CN1976725B Dimensional analysis of saccharide conjugates with GPC & SEC-MALS
08/29/2012CN1841066B Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
08/29/2012CN1678633B Anti-IGF-I receptor antibody
08/29/2012CN102652139A Pcsk9 antagonists
08/29/2012CN102649963A Human papillomavirus (HPV) L1-based recombinant adenovirus for preventing and treating esophagus cancer
08/29/2012CN102649948A Infectious bovine rhinotracheitis delta TK/delta gE gene deletion mark live vaccine and preparation method
08/29/2012CN102649818A CD4 protein-resistant monoclonal antibody and active fragment and application thereof
08/29/2012CN102649817A Monoclonal antibody for inhibiting formation of bacterial biofilm
08/29/2012CN102649816A Application of high mobility group box (HMGB) protein and antibody to preparation of ostrea rivularis anti-infection immune preparation
08/29/2012CN102649815A Application of AIF1 (Allograft Inflammatory Factor 1) protein and antibody to preparing southern oyster anti-infectious immune preparation
08/29/2012CN102648979A Purification of streptococcus pneumoniae type 3 polysaccharides
08/29/2012CN102028672B Microporous spongy film preparation and preparation method thereof
08/29/2012CN102000330B Nucleic acid vaccine adjuvant and construction method thereof
08/29/2012CN101948510B Molecular mimic peptide of type O foot and mouth disease virus VP2 epitope and applications thereof
08/29/2012CN101947316B Subunit mixed vaccine of human enterovirus 71
08/29/2012CN101940786B Application of immunogenic protein gene PilA of haemophilus parasuis
08/29/2012CN101928345B Human source antibody and humanization remolding method thereof
08/29/2012CN101732704B Method for preparing inactivated bivalent vaccine against rabbit hemorrhagic disease and pasteurella multocida disease
08/29/2012CN101659695B O-type aftosa synthetic peptide vaccine
08/29/2012CN101330927B Manufacture of vaccines that contain both hepatitis b virus surface antigen and surfactant
08/29/2012CN101318019B Compositions and methods for the therapy of inflammatory bowel disease
08/29/2012CN101257919B Antigen-and-drug vehicle which enables the changeover from the selective production of lgA antibody to the production of both of lgA and lgG antibodies, and transnasal/transmucosal vaccine using the vehicle
08/29/2012CN101028519B Pharmaceutical composition for treating immune diseases
08/28/2012US8252916 Expression vectors encoding epitopes of target-associated antigens and methods for their design
08/28/2012US8252915 Human transferase family members and uses thereof
08/28/2012US8252909 Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases
08/28/2012US8252907 Methods and compositions for inhibiting binding of IgE to a high affinity receptor
08/28/2012US8252902 Complexing antigen, antibodies; immunoassay
08/28/2012US8252897 Modified toxins
08/28/2012US8252747 Tissue adhesive sealant
08/28/2012US8252739 Albumin fusion proteins
08/28/2012US8252575 Newly isolated bacteriophage specific to klebsiella pneumoniae
08/28/2012US8252574 Pseudoinfectious flavivirus and uses thereof
08/28/2012US8252550 Targeting poly-γ-glutamic acid to treat Staphylococcus epidermidis and related infections
08/28/2012US8252295 Enzyme treatment of glucans
08/28/2012US8252293 Binding domain of Plasmodium reticulocyte binding proteins
08/28/2012US8252292 Eimeria vaccine for turkeys
08/28/2012US8252291 Bacteriocins and novel bacterial strains
08/28/2012US8252289 N protein of a virus of the paramyxoviridae family-protein of interest fusion proteins
08/28/2012US8252288 Methods of using multimeric complexes of antigens and an adjuvant
08/28/2012US8252287 Blood coagulation factor VIII activation-enhancing antibodies
08/28/2012US8252286 Antagonists of IL-6 to prevent or treat thrombosis
08/28/2012US8252285 Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
08/28/2012US8252284 High affinity, anti-human IgE antibodies
08/28/2012US8252283 Method for treating vascular disorders
08/28/2012US8252277 Virulent oncolytic herpes simplex virus strains engineered to counter the innate host response
08/28/2012US8252267 DKKL-1 splice product modulators for cancer diagnosis and therapy
08/28/2012CA2479414C Inhibition of the .beta.3 subunit of l-type ca2+ channels
08/28/2012CA2454073C Mutations in ion channels
08/28/2012CA2450470C Method for rapid screening of bacterial transformants and novel simian adenovirus proteins
08/28/2012CA2432978C Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
08/28/2012CA2399172C Cold-adapted equine influenza viruses
08/28/2012CA2395632C A bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
08/28/2012CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof
08/28/2012CA2284110C An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
08/23/2012WO2012112919A1 Stromal derived factor inhibition and cxcr4 blockade
08/23/2012WO2012112798A1 Methods to enhance cell-mediated immunity
08/23/2012WO2012112696A1 Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells
08/23/2012WO2012112691A1 Methods for enhancing immunogen specific immune responses by vectored vaccines
08/23/2012WO2012112645A1 Markers for identifying breast cancer treatment modalities
08/23/2012WO2012112528A1 Use of mdl-1 antagonists to treat spondylarthropathy
08/23/2012WO2012112489A2 Compositions and methods for the therapy and diagnosis of influenza
08/23/2012WO2012112079A1 IMPROVING CELLULAR IMMUNOTHERAPEUTIC VACCINES EFFICACY WITH GENE SUPPRESSION IN DENDRITIC CELLS AND T-LYMPHOCYTES USING SiRNA
08/23/2012WO2012111762A1 Highly concentrated anti-cd40 antibody pharmaceutical preparation
08/23/2012WO2012110968A2 Treatment of fistulizing crohn's disease
08/23/2012WO2012110639A1 Method for producing a dc vaccine against cancer
08/23/2012WO2012110500A1 Means and methods for improvement of synaptic dysfunction disorders
08/23/2012WO2012110490A1 Commercial scale process for production of prrsv
08/23/2012WO2012110489A2 Novel european prrsv strain
08/23/2012WO2012091564A3 A cross linking polypeptide comprising an hexameric single chain antibody binding mhc-mage complex that induces apoptosis
08/23/2012WO2012088388A9 Treating multiple myeloma
08/23/2012WO2012079000A4 Use of chimeric antigen receptor-modified t cells to treat cancer
08/23/2012WO2012078688A3 Humanized antibodies to liv-1 and use of same to treat cancer
08/23/2012WO2012039954A3 Reliable stabilization of n-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns
08/23/2012WO2012006369A3 Immunisation of large mammals with low doses of rna
08/23/2012WO2011143656A3 Compositions and methods of identifying tumor specific neoantigens
08/23/2012US20120214971 Novel anti-il13 antibodies and uses thereof
08/23/2012US20120214951 Preparation of polyphosphazene microspheres
08/23/2012US20120214737 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by nrg-2
1 ... 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 ... 1823